Tabula Rasa HealthCare (TRHC) falls 3.29% for September 14

Equities Staff  |

Tabula Rasa HealthCare Inc (NASDAQ: TRHC) shares fell 3.29%, or $0.98 per share, to close Tuesday at $28.80. After opening the day at $29.73, shares of Tabula Rasa HealthCare fluctuated between $30.21 and $28.67. 216,393 shares traded hands a decrease from their 30 day average of 292,849. Tuesday's activity brought Tabula Rasa HealthCare’s market cap to $715,486,579.

Tabula Rasa HealthCare is headquartered in Moorestown, New Jersey..

About Tabula Rasa HealthCare Inc

Tabula Rasa HealthCare provides medication safety solutions that empower healthcare professionals to optimize medication regimens and reduce medication-related risk, specifically targeting adverse drug events. TRHC's technology solutions, including DoseMeRx™ and MedWise™, improve patient outcomes, reduce hospitalizations, and lower healthcare costs. TRHC's extensive clinical tele-pharmacy network improves care for patients nationwide. Its solutions are trusted by health plans and pharmacies to help drive value-based payment results.

Visit Tabula Rasa HealthCare Inc’s profile for more information.

About The Nasdaq Stock Market

The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information on Tabula Rasa HealthCare Inc and to follow the company’s latest updates, you can visit the company’s profile page here: Tabula Rasa HealthCare Inc’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

Intuit To Acquire Mailchimp for $12 Billion in Cash and Stock
Consumer Brands Association Presses White House for More Clarity on Vaccine Mandates
Freshworks Shooting for $9 Billion IPO Valuation at Top End of Filing Range
Fauci Supports COVID-19 Vaccine Mandate for All Domestic Air Travel
Jobless Claims Fall to 310,000 — Lowest in Nearly 18 Months
200 Westerners Board Qatar Airways Flight From Kabul
Pennsylvania Republican Lawmakers Launch 'Election Integrity' Investigation
President Biden and Congressional Democrats Push for Civilian Climate Corps



Market Movers

Sponsored Financial Content